Adhese One F Upgrade in Direct Filling Therapy
Clinical Evaluation of AdheSE One F Upgrade in Direct Filling Therapy
1 other identifier
interventional
28
0 countries
N/A
Brief Summary
Investigation on the clinical performance of a new dental adhesive when used in direct filling therapy after phosphoric acid etching. Hypothesis: The new adhesive shows an acceptable clinical performance and allows a good filling quality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2012
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 20, 2014
CompletedFirst Posted
Study publicly available on registry
June 26, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 9, 2015
CompletedResults Posted
Study results publicly available
April 9, 2018
CompletedApril 1, 2025
March 1, 2025
3 years
June 20, 2014
March 12, 2018
March 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With Clinical Success
Clinical success is defined as no postoperative hypersensitivity and no loss of the restoration.
1 week
Secondary Outcomes (1)
Clinical Quality
3 years
Study Arms (1)
Adhese One F Upgrade
EXPERIMENTALAdhese One F Upgrade (AOFU) is administered after phosphoric acid etching (etch-and-rinse protocol).
Interventions
Eligibility Criteria
You may qualify if:
- indication for class I or II filling
- max. 2 restorations per patient
- vital teeth
- sufficient language skills
You may not qualify if:
- dry working field cannot be established
- if the patient is known to be allergic to any of the materials' ingredients
- severe systemic diseases
- pregnancy
- non-vital or pulpitic teeth
- indication for indirect restoration
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Results Point of Contact
- Title
- Dr. Erik Braziulis
- Organization
- Ivoclar Vivadent AG
Study Officials
- PRINCIPAL INVESTIGATOR
Arnd Peschke, Dr.
Ivoclar Vivadent AG
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2014
First Posted
June 26, 2014
Study Start
June 1, 2012
Primary Completion
June 1, 2015
Study Completion
September 9, 2015
Last Updated
April 1, 2025
Results First Posted
April 9, 2018
Record last verified: 2025-03